Placebo and nocebo effects in the neurological practice;Efeitos placebo e nocebo na prática neurológica

Arquivos de Neuro-Psiquiatria

Volumn 73, Issue 1, 2015, Pages 58-63

  Bittar, Caroline ^a   Nascimento, Osvaldo J M ^a  

^a HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

Author keywords

Clinical trials; Epilepsy; Headache; Multiple sclerosis; Neuropathic pain; Nocebo; Placebo

Indexed keywords

ACETYLSALICYLIC ACID; METOCLOPRAMIDE; PLACEBO; TRIPTAN DERIVATIVE;

ANALGESIA; ANTICIPATORY ANXIETY; CLUSTER HEADACHE; CONDITIONING; DEPRESSION; DIABETIC NEUROPATHY; DISEASE EXACERBATION; EPILEPSY; EXPECTATION; FIBROMYALGIA; HEADACHE; HUMAN; META ANALYSIS (TOPIC); MIGRAINE; MULTIPLE SCLEROSIS; NEUROLOGY; NEUROPATHIC PAIN; NOCEBO EFFECT; PHARMACOLOGICAL PARAMETERS; PLACEBO EFFECT; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; REWARD; SYSTEMATIC REVIEW (TOPIC); NEURALGIA;

HEADACHE; HUMANS; NEURALGIA; NEUROLOGY; NOCEBO EFFECT; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84921770219     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20140180     Document Type: Review

References (36)

1. Haga SB, Warner LR, O'Daniel J. The potential of a placebo/nocebo effect in pharmacogenetics. Public Health Genomics. 2009;12(3):158-62. http://dx.doi.org/10.1159/000189628
2. Sanderson C, Hardy J, Spruyt O, Currow DC. Placebo and nocebo effects in randomized controlled trials: the implications for research and practice. J Pain Symptom Manage. 2013;46(5):722-30. http://dx. doi.org/10.1016/j.jpainsymman.2012.12.005
3. Colloca L, Klinger R, Flor H, Bingel U. Placebo analgesia: psychological and neurobiological mechanisms. Pain. 2013;154(4):511-4. http://dx.doi.org/10.1016/j.pain.2013.02.002
4. Benedetti F, Amanzio M. Mechanisms of the placebo response. Pulm Pharmacol Ther. 2013;26(5):520-3. http://dx.doi.org/10.1016/j.pupt. 2013.01.006
5. Colloca L,Miller FG. Role of expectations in health. Curr Opin Psychiatry. 2011;24(2):149-55. http://dx.doi.org/10.1016/j.pupt.2013.01.006
6. Colloca L, Benedetti F. How prior experience shapes placebo analgesia. Pain. 2006;124(1-2):126-33. http://dx.doi.org/10.1016/j. pain.2006.04.005
7. Colloca L, Miller FG. How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1859-69. http://dx.doi.org/10.1098/rstb.2010.0398
8. Klosterhalfen S, Enck P. Neurophysiology and psychobiology of the placebo response. Curr Opin Psychiatry. 2008;21(2):189-95. http://dx. doi.org/10.1097/YCO.0b013e3282f50c36
9. Colloca L, Grillon C. Understanding placebo and nocebo responses for pain management. Curr Pain Headache Rep. 2014;18(6):419. http://dx.doi.org/10.1007/s11916-014-0419-2
10. Murray D, Stoessl AJ. Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions. Pharmacol Ther. 2013;140(3):306-18. http://dx.doi.org/10.1016/j. pharmthera.2013.07.009
11. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59(1):565-90. http://dx.doi.org/10.1146/annurev.psych. 59.113006.095941
12. Diener HC, Schorn CF, Bingel U, Dodick DW. The importance of placebo in headache search. Cephalalgia. 2008;28(10):1003-11. http://dx.doi.org/10.1111/j.1468-2982.2008.01660.x
13. Loder E, Goldstein R, Biondi D. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls. Cephalalgia. 2005;25(2):124-31. http://dx.doi.org/10.1111/ j.1468-2982.2004.00817.x
14. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007;68(15):1178-82. http://dx.doi.org/10.1212/01.wnl.0000259085. 61898.9e
15. Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136(3):380-7. http://dx.doi.org/10.1016/ j.pain.2007.08.013
16. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain. 2006;122(1-2):156-62. http://dx.doi.org/10.1016/j.pain.2006.01.030
17. Häuser W, Bartram-Wunn E, Bartram C, Reinecke H, Tölle T. Systematic review: placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy- magnitude and patient-related predictors. Pain. 2011;152(8):1709-17. http://dx. doi.org/10.1016/j.pain.2011.01.050
18. Kennedy WP. The nocebo reaction. Med Word. 1961;95:203-5.
19. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron. 2008;59(2):195-206. http://dx.doi. org/10.1016/j.neuron.2008.06.030
20. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. J Neurosci. 2003;23(10):4315-23.
21. Ploghaus A, Narain C, Beckmann CF, Clare S, Bantick S, Wise R et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci. 2001;21(24):9896-903.
22. Paulson PE, Minoshima S, Morrow TJ, Casey KL. Gender differences in pain perception and patterns of cerebral activation during noxious heat stimulation in humans. Pain. 1998;76(1-2):223-9. http://dx.doi. org/10.1016/S0304-3959(98)00048-7
23. Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain. 2008;136(1-2):211-8. http://dx.doi.org/10.1016/ j.pain.2008.02.006
24. Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307(6):567-8. http://dx. doi.org/10.1001/jama.2012.115
25. Rogers MP. Headaches and the nocebo effect. Headache. 2003;43(10):1113-5. http://dx.doi.org/10.1046/j.1526-4610.2003.03216.x
26. Reuter U, Sanchez del Rio M, Carpay JA, Boes CJ, Silberstein SD. Placebo adverse events in headache trials: headache as an adverse event of placebo. Cephalalgia. 2003;23(7):496-503. http://dx.doi.org/ 10.1046/j.1468-2982.2003.00530.x
27. Mitsikostas DD, Mantonakis LI, Chalarakis NG. Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia. 2010;31(5):550-61. http://dx. doi.org/10.1177/0333102410391485
28. Uhlenhuth EH, Alexander PE, Dempsey GM, Jones W, Coleman BS, Swiontek AM. Medication side effects in anxious patients: negative placebo responses. J Affect Disord. 1998;47(1-3):183-90. http://dx. doi.org/10.1016/S0165-0327(97)00125-0
29. Stam AH, Vries B, Janssens AC, Vanmolkot KR, Aulchenko YS, Henneman P et al. Shared genetic factors in migraine and depression: evidence from a genetic isolate. Neurology. 2010;74(4):288-94. http://dx. doi.org/10.1212/WNL.0b013e3181cbcd19
30. Mitsikostas DD. Nocebo in headaches: implications for clinical practice and trial design. Curr Nerurol Neurosci Rep. 2011;12(2):132-7. http://dx.doi.org/10.1007/s11910-011-0245-4
31. O'Connor AB. Neuropathic pain: quality-of-life impact, costs ans cost effectiveness of therapy. Pharmacoeconomics. 2009;27(2):95-112. http://dx.doi.org/10.2165/00019053-200927020-00002
32. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630-5. http://dx.doi.org/10.1212/01.wnl.0000282763. 29778.59
33. Papadopoulos D, Mitsikostas DD. A meta-analytic approach to estimating nocebo effects in neuropathic pain trials. J Neurol. 2012;259:(3)436-47. http://dx.doi.org/10.1007/s00415-011-6197-4
34. Jensen MP, Romano JM, Turner JA, Good AB, Wald LH. Patient beliefs predict patient functioning: further support for a cognitive-behavioural model of chronic pain. Pain. 1999;81(1-2):95-104. http://dx.doi.org/ 10.1016/S0304-3959(99)00005-6
35. Klosterhalfen S, Kellermann S, Braun S, Kowalski A, Schrauth M, Zipfel S et al. Gender and the nocebo response following conditioning and expectancy. J Psychosom Res. 2009;66(4):323-8. http://dx.doi.org/ 10.1016/j.jpsychores.2008.09.019
36. Manchikanti L, Giordano J, Fellows B, Hirsch J. Placebo and nocebo in interventional pain management: a friend or a foe - or simply foes? Pain Physician. 2011;14(2):E157-75.